Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
Lahey Hospital and Medical Center
mi
from
Burlington, MA
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
Lahey Hospital and Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
Minneapolis Veterans Medical Center
mi
from
Minneapolis, MN
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
Minneapolis Veterans Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
University of Rochester
mi
from
Rochester, NY
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
Urology San Antonio Research
mi
from
San Antonio, TX
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
Urology San Antonio Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
University of Alabama at Birmingham Cancer Center
mi
from
Birmingham, AL
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
University of Alabama at Birmingham Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily x 5 Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies
Status: Enrolling
Updated:  8/26/2015
Cancer Therapy and Research Center, University of Texas Health Center at San Antonio
mi
from
San Antonio, TX
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily x 5 Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies
Status: Enrolling
Updated: 8/26/2015
Cancer Therapy and Research Center, University of Texas Health Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
3'-Deoxy-3'(18) F-Fluorothymidine Positron Emission Tomography/Computed Tomography (PET/CT) for Initial Staging, Radiotherapy Target Definition, and Assessment of Response to Therapy in Patients With Esophageal Cancer: A Pilot Study
Status: Enrolling
Updated:  8/27/2015
Brigham and Women's Hosp
mi
from
Boston, MA
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
3'-Deoxy-3'(18) F-Fluorothymidine Positron Emission Tomography/Computed Tomography (PET/CT) for Initial Staging, Radiotherapy Target Definition, and Assessment of Response to Therapy in Patients With Esophageal Cancer: A Pilot Study
Status: Enrolling
Updated: 8/27/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
3'-Deoxy-3'(18) F-Fluorothymidine Positron Emission Tomography/Computed Tomography (PET/CT) for Initial Staging, Radiotherapy Target Definition, and Assessment of Response to Therapy in Patients With Esophageal Cancer: A Pilot Study
Status: Enrolling
Updated:  8/27/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
3'-Deoxy-3'(18) F-Fluorothymidine Positron Emission Tomography/Computed Tomography (PET/CT) for Initial Staging, Radiotherapy Target Definition, and Assessment of Response to Therapy in Patients With Esophageal Cancer: A Pilot Study
Status: Enrolling
Updated: 8/27/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
3'-Deoxy-3'(18) F-Fluorothymidine Positron Emission Tomography/Computed Tomography (PET/CT) for Initial Staging, Radiotherapy Target Definition, and Assessment of Response to Therapy in Patients With Esophageal Cancer: A Pilot Study
Status: Enrolling
Updated:  8/27/2015
Massachusetts General Hospital
mi
from
Boston, MA
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
3'-Deoxy-3'(18) F-Fluorothymidine Positron Emission Tomography/Computed Tomography (PET/CT) for Initial Staging, Radiotherapy Target Definition, and Assessment of Response to Therapy in Patients With Esophageal Cancer: A Pilot Study
Status: Enrolling
Updated: 8/27/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Salt Lake City, UT
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Scottsdale, AZ
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Sarasota, FL
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Detroit, MI
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Columbus, OH
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Greenville, SC
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Greenville, SC
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Nashville, TN
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Nedlands,
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Nedlands,
Click here to add this to my saved trials
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Scottsdale, AZ
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Memphis, TN
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Nashville, TN
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
San Antonio, TX
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Salt Lake City, UT
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated:  8/27/2015
GSK Investigational Site
mi
from
Heidelberg,
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
Status: Enrolling
Updated: 8/27/2015
GSK Investigational Site
mi
from
Heidelberg,
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
Denver Health Medical Center
mi
from
Denver, CO
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
Boston University Cancer Research Center
mi
from
Boston, MA
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
Boston University Cancer Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
Montefiore Medical Center
mi
from
Bronx, NY
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
Laser Surgery Care
mi
from
New York, NY
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
Laser Surgery Care
mi
from
New York, NY
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated:  8/27/2015
Benaroya Research Institute at Virginia Mason Medical Center
mi
from
Seattle, WA
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men
Status: Enrolling
Updated: 8/27/2015
Benaroya Research Institute at Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated:  8/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated:  8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated: 8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
A PHASE I TRIAL OF ALLOREACTIVE NK CELLS INFUSION FOLLOWING TRANSPLANTATION OF HAPLOTYPE MISMATCHED, KIR MISMATCHED HIGHLY PURIFIED CD34 CELLS IN PATIENTS WITH ADVANCED OR REFRACTORY MYELOID MALIGNANCIES
Status: Enrolling
Updated:  8/28/2015
Indiana University Cancer Center
mi
from
Indianapolis, IN
A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
A PHASE I TRIAL OF ALLOREACTIVE NK CELLS INFUSION FOLLOWING TRANSPLANTATION OF HAPLOTYPE MISMATCHED, KIR MISMATCHED HIGHLY PURIFIED CD34 CELLS IN PATIENTS WITH ADVANCED OR REFRACTORY MYELOID MALIGNANCIES
Status: Enrolling
Updated: 8/28/2015
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
Determination of Tumor SUV by FDG-PET/CT Before and After Cetuximab in Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  8/28/2015
Washington University
mi
from
St. Louis, MO
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
Determination of Tumor SUV by FDG-PET/CT Before and After Cetuximab in Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 8/28/2015
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
Determination of Tumor SUV by FDG-PET/CT Before and After Cetuximab in Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  8/28/2015
University of Louisville
mi
from
Louisville, KY
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
Determination of Tumor SUV by FDG-PET/CT Before and After Cetuximab in Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 8/28/2015
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
ABX209: Phase II Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer.
Status: Enrolling
Updated:  8/28/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
ABX209: Phase II Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer.
Status: Enrolling
Updated: 8/28/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated:  8/28/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated: 8/28/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated:  8/28/2015
Kansas City Veterans Administration Medical Center
mi
from
Kansas City, MO
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated: 8/28/2015
Kansas City Veterans Administration Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated:  8/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated: 8/28/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated:  8/28/2015
Bayside Endoscopy Center
mi
from
Providence, RI
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated: 8/28/2015
Bayside Endoscopy Center
mi
from
Providence, RI
Click here to add this to my saved trials
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated:  8/28/2015
Baylor University Medical Center
mi
from
Dallas, TX
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated: 8/28/2015
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated:  8/28/2015
Cliniques Universitaires Saint-Luc
mi
from
Brussels,
Third Eye Retroscope Randomized Clinical Evaluation
Third Eye Retroscope Randomized Clinical Evaluation (The "TERRACE" Study)
Status: Enrolling
Updated: 8/28/2015
Cliniques Universitaires Saint-Luc
mi
from
Brussels,
Click here to add this to my saved trials